EFuturesCFO · Pharmaceutical Suite
Commercial Launch & Market Access
Model new product launch trajectory given WAP pricing, formulary access, payer mix, gross-to-net discounts, and patient uptake. Project quarterly revenue through peak.
Executive Summary
Quarterly Launch Curve (12 Quarters)
Gross revenue, net revenue, and market share ramp
Payer Mix & Net Realization
Net revenue by payer channel at peak
Revenue Levers
Ranked by annual net revenue impact
Executive Recommendations
Methodology
Addressable = Target × Formulary Access. Peak Patients = Addressable × Share × Compliance. Net Revenue = Gross × (1 − GTN). GTN varies by payer: Commercial lowest, 340B/Medicaid highest. Launch curve uses sigmoid ramp over specified months. Quarterly seasonality ±5%.